Literature DB >> 25867491

Biolistic transformation of a fluorescent tagged gene into the opportunistic fungal pathogen Cryptococcus neoformans.

Tonya Taylor1, Indrani Bose2, Taylor Luckie1, Kerry Smith3.   

Abstract

The basidiomycete Cryptococcus neoformans, an invasive opportunistic pathogen of the central nervous system, is the most frequent cause of fungal meningitis worldwide resulting in more than 625,000 deaths per year worldwide. Although electroporation has been developed for the transformation of plasmids in Cryptococcus, only biolistic delivery provides an effective means to transform linear DNA that can be integrated into the genome by homologous recombination.  Acetate has been shown to be a major fermentation product during cryptococcal infection, but the significance of this is not yet known. A bacterial pathway composed of the enzymes xylulose-5-phosphate/fructose-6-phosphate phosphoketolase (Xfp) and acetate kinase (Ack) is one of three potential pathways for acetate production in C. neoformans. Here, we demonstrate the biolistic transformation of a construct, which has the gene encoding Ack fused to the fluorescent tag mCherry, into C. neoformans. We then confirm integration of the ACK-mCherry fusion into the ACK locus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25867491      PMCID: PMC4401375          DOI: 10.3791/52666

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans.

Authors:  R C Davidson; M C Cruz; R A Sia; B Allen; J A Alspaugh; J Heitman
Journal:  Fungal Genet Biol       Date:  2000-02       Impact factor: 3.495

2.  Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target.

Authors:  M Del Poeta; D L Toffaletti; T H Rude; C C Dykstra; J Heitman; J R Perfect
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

3.  Metabolites released by Cryptococcus neoformans var. neoformans and var. gattii differentially affect human neutrophil function.

Authors:  Lesley Wright; William Bubb; John Davidson; Rosemary Santangelo; Mark Krockenberger; Uwe Himmelreich; Tania Sorrell
Journal:  Microbes Infect       Date:  2002-11       Impact factor: 2.700

4.  Identification of metabolites of importance in the pathogenesis of pulmonary cryptococcoma using nuclear magnetic resonance spectroscopy.

Authors:  Uwe Himmelreich; Chris Allen; Susan Dowd; Richard Malik; B Philip Shehan; Carolyn Mountford; Tania C Sorrell
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

5.  Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation.

Authors:  J C Edman; K J Kwon-Chung
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

6.  High frequency transformation of Cryptococcus neoformans and Cryptococcus gattii by Agrobacterium tumefaciens.

Authors:  Carol M McClelland; Yun C Chang; K J Kwon-Chung
Journal:  Fungal Genet Biol       Date:  2005-11       Impact factor: 3.495

7.  Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors.

Authors:  W A Bubb; L C Wright; M Cagney; R T Santangelo; T C Sorrell; P W Kuchel
Journal:  Magn Reson Med       Date:  1999-09       Impact factor: 4.668

8.  Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA.

Authors:  D L Toffaletti; T H Rude; S A Johnston; D T Durack; J R Perfect
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

9.  Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.

Authors:  Y C Chang; K J Kwon-Chung
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

10.  Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host.

Authors:  Michael S Price; Marisol Betancourt-Quiroz; Jennifer L Price; Dena L Toffaletti; Haily Vora; Guanggan Hu; James W Kronstad; John R Perfect
Journal:  MBio       Date:  2011-06-07       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.